{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T16:54:59Z","timestamp":1743267299705,"version":"3.37.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"DOI":"10.1186\/s12955-025-02338-2","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T03:11:16Z","timestamp":1738638676000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tools used to measure quality of life in adults with cystic fibrosis\u2013 a systematic review"],"prefix":"10.1186","volume":"23","author":[{"given":"Dorota","family":"Snop-Perkowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"\u015awitalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Wnuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"Olszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Augustynowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"issue":"1","key":"2338_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","volume":"8","author":"SC Bell","year":"2020","unstructured":"Bell SC, Mall MA, Gutierrez H, et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med. 2020;8(1):65\u2013124.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"2338_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00408-023-00658-y","volume":"201","author":"N Smirnova","year":"2023","unstructured":"Smirnova N, Lowers J, Magee MJ, et al. Pulmonary function and quality of life in adults with cystic fibrosis. Lung. 2023;201(6):635\u20139.","journal-title":"Lung"},{"issue":"7","key":"2338_CR3","first-page":"1351","volume":"10","author":"J Ancel","year":"2022","unstructured":"Ancel J, Launois C, Perotin JM, et al. Health-related quality of life in adults with cystic fibrosis: familial, occupational, Social, and Mental Health predictors. Healthc (Basel). 2022;10(7):1351.","journal-title":"Healthc (Basel)"},{"issue":"2","key":"2338_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.hrtlng.2018.08.003","volume":"48","author":"L Tomaszek","year":"2019","unstructured":"Tomaszek L, D\u0119bska G, Cepuch G, et al. Evaluation of quality of life predictors in adolescents and young adults with cystic fibrosis. Heart Lung. 2019;48(2):159\u201365.","journal-title":"Heart Lung"},{"issue":"2","key":"2338_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/MCP.0000000000000244","volume":"22","author":"AL Quittner","year":"2016","unstructured":"Quittner AL, Saez-Flores E, Barton JD. The psychological burden of cystic fibrosis. Curr Opin Pulm Med. 2016;22(2):187\u201391.","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"2338_CR6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.ccm.2022.06.014","volume":"43","author":"CJ Bathgate","year":"2022","unstructured":"Bathgate CJ, Hjelm M, Filigno SS, et al. Management of Mental Health in cystic fibrosis. Clin Chest Med. 2022;43(4):791\u2013810.","journal-title":"Clin Chest Med"},{"issue":"1","key":"2338_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chest.2022.07.004","volume":"163","author":"PR Burgel","year":"2023","unstructured":"Burgel PR, Burnet E, Regard L, et al. The changing epidemiology of cystic fibrosis: the implications for Adult Care. Chest. 2023;163(1):89\u201399.","journal-title":"Chest"},{"issue":"3","key":"2338_CR8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jcf.2020.02.015","volume":"19","author":"SG Kapnadak","year":"2020","unstructured":"Kapnadak SG, Dimango E, Hadjiliadis D, et al. Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease. J Cyst Fibros. 2020;19(3):344\u201354.","journal-title":"J Cyst Fibros"},{"key":"2338_CR9","doi-asserted-by":"publisher","first-page":"100182","DOI":"10.1016\/j.clinsp.2023.100182","volume":"78","author":"A Raguragavan","year":"2023","unstructured":"Raguragavan A, Jayabalan D, Saxena A. Health-related quality of life following lung transplantation for cystic fibrosis: a systematic review. Clin (Sao Paulo). 2023;78:100182.","journal-title":"Clin (Sao Paulo)"},{"issue":"2","key":"2338_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","volume":"17","author":"C Castellani","year":"2018","unstructured":"Castellani C, Duff AJA, Bell SC, et al. ECFS best practice guidelines: the 2018 revision. J Cyst Fibros. 2018;17(2):153\u201378.","journal-title":"J Cyst Fibros"},{"issue":"10","key":"2338_CR11","doi-asserted-by":"publisher","first-page":"e033867","DOI":"10.1136\/bmjopen-2019-033867","volume":"10","author":"I Ratnayake","year":"2020","unstructured":"Ratnayake I, Ahern S, Ruseckaite R. A systematic review of patient-reported outcome measures (PROMs) in cystic fibrosis. BMJ Open. 2020;10(10):e033867.","journal-title":"BMJ Open"},{"issue":"1","key":"2338_CR12","doi-asserted-by":"publisher","first-page":"e000927","DOI":"10.1136\/bmjresp-2021-000927","volume":"8","author":"I Ratnayake","year":"2021","unstructured":"Ratnayake I, Ahern S, Ruseckaite R. Acceptability of patient reported outcome measures (PROMs) in a cystic fibrosis data registry. BMJ Open Respir Res. 2021;8(1):e000927.","journal-title":"BMJ Open Respir Res"},{"issue":"21","key":"2338_CR13","first-page":"2873","volume":"11","author":"W Gruber","year":"2023","unstructured":"Gruber W, Welsner M, Blosch C, et al. Long-term Follow-Up of Health-Related Quality of Life and short-term intervention with CFTR Modulator Therapy in adults with cystic fibrosis: evaluation of changes over several years with or without 33 weeks of CFTR modulator therapy. Healthc (Basel). 2023;11(21):2873.","journal-title":"Healthc (Basel)"},{"key":"2338_CR14","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3389\/fphar.2019.01662","volume":"10","author":"M Lopes-Pacheco","year":"2020","unstructured":"Lopes-Pacheco M. CFTR modulators: the changing Face of cystic fibrosis in the era of Precision Medicine. Front Pharmacol. 2020;10:1662.","journal-title":"Front Pharmacol"},{"issue":"11","key":"2338_CR15","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/cells11111769","volume":"11","author":"L Regard","year":"2022","unstructured":"Regard L, Martin C, Burnet E, et al. CFTR Modulators in people with cystic fibrosis: real-world evidence in France. Cells. 2022;11(11):1769.","journal-title":"Cells"},{"key":"2338_CR16","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"2338_CR17","doi-asserted-by":"crossref","unstructured":"Snop-Perkowska D, \u015awitalski J, Wnuk K et al. Tools used to measure quality of life in adults suffering from cystic fibrosis - a systematic review. https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42023491030. Date last accessed: Feb 02 2024.","DOI":"10.1186\/s12955-025-02338-2"},{"issue":"7","key":"2338_CR18","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","volume":"63","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737\u201345.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"2338_CR19","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s11136-017-1765-4","volume":"27","author":"LB Mokkink","year":"2018","unstructured":"Mokkink LB, de Vet HCW, Prinsen CAC, et al. COSMIN Risk of Bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1171\u20139.","journal-title":"Qual Life Res"},{"issue":"5","key":"2338_CR20","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s11136-018-1829-0","volume":"27","author":"CB Terwee","year":"2018","unstructured":"Terwee CB, Prinsen CAC, Chiarotto A, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res. 2018;27(5):1159\u201370.","journal-title":"Qual Life Res"},{"issue":"5","key":"2338_CR21","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s11136-018-1798-3","volume":"27","author":"CAC Prinsen","year":"2018","unstructured":"Prinsen CAC, Mokkink LB, Bouter LM, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1147\u201357.","journal-title":"Qual Life Res"},{"key":"2338_CR22","doi-asserted-by":"crossref","unstructured":"Mokkink LB, Prinsesn CAC, Patrick DL et al. COSMIN methodology for systematic reviews of Patient-Reported Outcome Measures (PROMs)\u2013 user manual. https:\/\/cosmin.nl\/wp-content\/uploads\/COSMIN-syst-review-for-PROMs-manual_version-1_feb-2018.pdf. Date last accessed: Feb 02 2024.","DOI":"10.1007\/978-3-319-69909-7_2972-2"},{"issue":"4","key":"2338_CR23","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1378\/chest.128.4.2347","volume":"128","author":"AL Quittner","year":"2005","unstructured":"Quittner AL, Buu A, Messer MA, et al. Development and validation of the cystic fibrosis questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest. 2005;128(4):2347\u201354.","journal-title":"Chest"},{"issue":"6","key":"2338_CR24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jcf.2008.06.006","volume":"7","author":"V Bregnballe","year":"2008","unstructured":"Bregnballe V, Thastum M, Lund LD, et al. Validation of the Danish version of the revised cystic fibrosis quality of life questionnaire in adolescents and adults (CFQ-R14+). J Cyst Fibros. 2008;7(6):531\u20136.","journal-title":"J Cyst Fibros"},{"issue":"2","key":"2338_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2223\/JPED.1463","volume":"82","author":"T Rozov","year":"2006","unstructured":"Rozov T, Cunha MT, Nascimento O, et al. Linguistic validation of cystic fibrosis quality of life questionnaires. J Pediatr (Rio J). 2006;82(2):151\u20136.","journal-title":"J Pediatr (Rio J)"},{"issue":"2","key":"2338_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0031-3939(09)70151-9","volume":"84","author":"D Sands","year":"2009","unstructured":"Sands D, Borawska-Kowalczyk U. Validation of Polish version of\u2013 specific quality of life questionnaire for cystic fibrosis (CFQ-R). Pediatria Polska. 2009;84(2):165\u201372.","journal-title":"Pediatria Polska"},{"issue":"4","key":"2338_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.arbres.2010.01.006","volume":"46","author":"G Olveira","year":"2010","unstructured":"Olveira G, Olveira C, Gaspar I, et al. Validation of the Spanish version of the revised cystic fibrosis quality of Life Questionnaire in adolescents and adults (CFQR 14\u2009+\u2009Spain). Arch Bronconeumol. 2010;46(4):165\u201375.","journal-title":"Arch Bronconeumol"},{"issue":"7","key":"2338_CR28","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s11136-011-0036-z","volume":"21","author":"AL Quittner","year":"2012","unstructured":"Quittner AL, Sawicki GS, McMullen A, et al. Psychometric evaluation of the cystic fibrosis questionnaire-revised in a national sample. Qual Life Res. 2012;21(7):1267\u201378.","journal-title":"Qual Life Res"},{"issue":"1","key":"2338_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/03009734.2016.1225871","volume":"122","author":"J Hochw\u00e4lder","year":"2017","unstructured":"Hochw\u00e4lder J, Bergsten Brucefors A, Hjelte L. Psychometric evaluation of the Swedish translation of the revised cystic fibrosis questionnaire in adults. Ups J Med Sci. 2017;122(1):61\u20136.","journal-title":"Ups J Med Sci"},{"issue":"5","key":"2338_CR30","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jcf.2017.10.015","volume":"17","author":"A Sol\u00e9","year":"2018","unstructured":"Sol\u00e9 A, Olveira C, P\u00e9rez I, et al. Development and electronic validation of the revised cystic fibrosis questionnaire (CFQ-R Teen\/Adult): New tool for monitoring psychosocial health in CF. J Cyst Fibros. 2018;17(5):672\u20139.","journal-title":"J Cyst Fibros"},{"issue":"3","key":"2338_CR31","doi-asserted-by":"publisher","first-page":"312","DOI":"10.32641\/andespediatr.v93i3.3871","volume":"93","author":"TS Navarro","year":"2022","unstructured":"Navarro TS, Boza CML, Molina MY, et al. Content validation for the Chilean population of the quality of life assessment instrument in children, adolescents and adults with cystic fibrosis: CFQ-R CYSTIC FIBROSIS QUESTIONNAIRE-REVISED version in Spanish, Chile. Andes Pediatr. 2022;93(3):312\u201326.","journal-title":"Andes Pediatr"},{"issue":"1","key":"2338_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1023\/A:1022037320039","volume":"12","author":"B Henry","year":"2003","unstructured":"Henry B, Aussage P, Grosskopf C, et al. Development of the cystic fibrosis questionnaire (CFQ) for assessing quality of life in pediatric and adult patients. Qual Life Res. 2003;12(1):63\u201376.","journal-title":"Qual Life Res"},{"issue":"1","key":"2338_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jcf.2003.12.006","volume":"3","author":"PH Klijn","year":"2004","unstructured":"Klijn PH, van Stel HF, Quittner AL, et al. Validation of the Dutch cystic fibrosis questionnaire (CFQ) in adolescents and adults. J Cyst Fibros. 2004;3(1):29\u201336.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"2338_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/A:1022011704399","volume":"12","author":"K Wenninger","year":"2003","unstructured":"Wenninger K, Aussage P, Wahn U, et al. The revised German cystic fibrosis questionnaire: validation of a disease-specific health-related quality of life instrument. Qual Life Res. 2003;12(1):77\u201385.","journal-title":"Qual Life Res"},{"issue":"4","key":"2338_CR35","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jval.2022.12.002","volume":"26","author":"S Acaster","year":"2023","unstructured":"Acaster S, Mukuria C, Rowen D, et al. Development of the cystic fibrosis questionnaire-Revised-8 dimensions: estimating utilities from the cystic fibrosis questionnaire-revised. Value Health. 2023;26(4):567\u201378.","journal-title":"Value Health"},{"issue":"11","key":"2338_CR36","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1136\/thorax.55.11.946","volume":"55","author":"L Gee","year":"2000","unstructured":"Gee L, Abbott J, Conway SP, et al. Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax. 2000;55(11):946\u201354.","journal-title":"Thorax"},{"issue":"137","key":"2338_CR37","first-page":"340","volume":"23","author":"G D\u0119bska","year":"2007","unstructured":"D\u0119bska G, Mazurek H. Validation of Polish version of CFQoL in patients with cystic fibrosis. Pol Merkur Lekarski. 2007;23(137):340\u20133.","journal-title":"Pol Merkur Lekarski"},{"issue":"2","key":"2338_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jcf.2007.06.003","volume":"7","author":"F Monti","year":"2008","unstructured":"Monti F, Lupi F, Gobbi F, et al. Validation of the Italian version of the cystic fibrosis quality of Life Questionnaire (CFQoL), a disease specific measure for adults and adolescents with cystic fibrosis. J Cyst Fibros. 2008;7(2):116\u201322.","journal-title":"J Cyst Fibros"},{"key":"2338_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fphar.2012.00038","volume":"3","author":"MS Salek","year":"2012","unstructured":"Salek MS, Jones S, Rezaie M, et al. Do patient-reported outcomes have a role in the management of patients with cystic fibrosis? Front Pharmacol. 2012;3:38.","journal-title":"Front Pharmacol"},{"issue":"4","key":"2338_CR40","first-page":"205","volume":"84","author":"M Stofa","year":"2016","unstructured":"Stofa M, Xanthos T, Ekmektzoglou K, et al. Quality of life in adults with cystic fibrosis: the Greek experience. Pneumonol Alergol Pol. 2016;84(4):205\u201311.","journal-title":"Pneumonol Alergol Pol"},{"issue":"1","key":"2338_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1023\/A:1016711704283","volume":"10","author":"L Goldbeck","year":"2001","unstructured":"Goldbeck L, Schmitz TG. Comparison of three generic questionnaires measuring quality of life in adolescents and adults with cystic fibrosis: the 36-item short form health survey, the quality of life profile for chronic diseases, and the questions on life satisfaction. Qual Life Res. 2001;10(1):23\u201336.","journal-title":"Qual Life Res"},{"issue":"3","key":"2338_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1569-1993(02)00079-6","volume":"1","author":"L Gee","year":"2002","unstructured":"Gee L, Abbott J, Conway SP, et al. Validation of the SF-36 for the assessment of quality of life in adolescents and adults with cystic fibrosis. J Cyst Fibros. 2002;1(3):137\u201345.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"2338_CR43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1378\/chest.123.1.42","volume":"123","author":"L Goldbeck","year":"2003","unstructured":"Goldbeck L, Schmitz TG, Henrich G, et al. Questions on life satisfaction for adolescents and adults with cystic fibrosis: development of a disease-specific questionnaire. Chest. 2003;123(1):42\u20138.","journal-title":"Chest"},{"issue":"1\u20132","key":"2338_CR44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1023\/A:1026437214170","volume":"8","author":"J Bradley","year":"1999","unstructured":"Bradley J, Dempster M, Wallace E, Elborn S. The adaptations of a quality of life questionnaire for routine use in clinical practice: the chronic respiratory disease questionnaire in cystic fibrosis. Qual Life Res. 1999;8(1\u20132):65\u201371.","journal-title":"Qual Life Res"},{"issue":"4","key":"2338_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1157\/13100539","volume":"43","author":"A Padilla","year":"2007","unstructured":"Padilla A, Olveira G, Olveira C, et al. Validity and reliability of the St George\u2019s respiratory questionnaire in adults with cystic fibrosis. Arch Bronconeumol. 2007;43(4):205\u201311.","journal-title":"Arch Bronconeumol"},{"issue":"8","key":"2338_CR46","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.healun.2015.03.005","volume":"34","author":"BM Hoffman","year":"2015","unstructured":"Hoffman BM, Stonerock GL, Smith PJ, et al. Development and psychometric properties of the Pulmonary-specific quality-of-life scale in lung transplant patients. J Heart Lung Transpl. 2015;34(8):1058\u201365.","journal-title":"J Heart Lung Transpl"},{"key":"2338_CR47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1477-7525-9-105","volume":"9","author":"AM Yohannes","year":"2011","unstructured":"Yohannes AM, Dodd M, Morris J, et al. Reliability and validity of a single item measure of quality of life scale for adult patients with cystic fibrosis. Health Qual Life Outcomes. 2011;9:105.","journal-title":"Health Qual Life Outcomes"},{"key":"2338_CR48","doi-asserted-by":"publisher","first-page":"105992","DOI":"10.1016\/j.rmed.2020.105992","volume":"168","author":"J Pott","year":"2020","unstructured":"Pott J, Krill A, Wilkens H, et al. Easy measurement of health related quality of life in patients with cystic fibrosis by the COPD assessment test (CAT) - a pilot study. Respir Med. 2020;168:105992.","journal-title":"Respir Med"},{"issue":"3","key":"2338_CR49","doi-asserted-by":"publisher","first-page":"00120","DOI":"10.1183\/23120541.00120-2021","volume":"7","author":"BM Button","year":"2021","unstructured":"Button BM, Wilson LM, Burge AT, et al. The AWESCORE, a patient-reported outcome measure: development, feasibility, reliability, validity and responsiveness for adults with cystic fibrosis. ERJ Open Res. 2021;7(3):00120\u20132021.","journal-title":"ERJ Open Res"},{"key":"2338_CR50","doi-asserted-by":"publisher","first-page":"102116","DOI":"10.1016\/j.eclinm.2023.102116","volume":"62","author":"D Muilwijk","year":"2023","unstructured":"Muilwijk D, van Paridon TJ, van der Heijden DC, et al. Development and validation of a novel personalized electronic patient-reported outcome measure to assess quality of life (Q-LIFE): a prospective observational study in people with cystic fibrosis. EClinicalMedicine. 2023;62:102116.","journal-title":"EClinicalMedicine"},{"issue":"11","key":"2338_CR51","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.medcli.2021.06.025","volume":"158","author":"P Blanco-Orive","year":"2022","unstructured":"Blanco-Orive P, Del Corral T, Mart\u00edn-Casas P, et al. Quality of life and exercise tolerance tools in children\/adolescents with cystic fibrosis: systematic review. Med Clin (Barc). 2022;158(11):519\u201330.","journal-title":"Med Clin (Barc)"},{"issue":"160","key":"2338_CR52","doi-asserted-by":"publisher","first-page":"200354","DOI":"10.1183\/16000617.0354-2020","volume":"30","author":"C McLeod","year":"2021","unstructured":"McLeod C, Wood J, Tong A, et al. The measurement properties of tests and tools used in cystic fibrosis studies: a systematic review. Eur Respir Rev. 2021;30(160):200354.","journal-title":"Eur Respir Rev"},{"issue":"10","key":"2338_CR53","doi-asserted-by":"publisher","first-page":"e0276310","DOI":"10.1371\/journal.pone.0276310","volume":"17","author":"S Gursli","year":"2022","unstructured":"Gursli S, Quittner A, Jahnsen RB, et al. Airway clearance physiotherapy and health-related quality of life in cystic fibrosis. PLoS ONE. 2022;17(10):e0276310.","journal-title":"PLoS ONE"},{"issue":"6","key":"2338_CR54","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S2213-2600(22)00504-5","volume":"11","author":"AZ Uluer","year":"2023","unstructured":"Uluer AZ, MacGregor G, Azevedo P, et al. Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials. Lancet Respir Med. 2023;11(6):550\u201362.","journal-title":"Lancet Respir Med"},{"key":"2338_CR55","doi-asserted-by":"publisher","first-page":"1179208","DOI":"10.3389\/fphar.2023.1179208","volume":"14","author":"L Piehler","year":"2023","unstructured":"Piehler L, Thalemann R, Lehmann C, et al. Effects of elexacaftor\/tezacaftor\/ivacaftor therapy on mental health of patients with cystic fibrosis. Front Pharmacol. 2023;14:1179208.","journal-title":"Front Pharmacol"},{"issue":"5","key":"2338_CR56","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jcf.2018.12.004","volume":"18","author":"PA Flume","year":"2019","unstructured":"Flume PA, Suthoff ED, Kosinski M, et al. Measuring recovery in health-related quality of life during and after pulmonary exacerbations in patients with cystic fibrosis. J Cyst Fibros. 2019;18(5):737\u201342.","journal-title":"J Cyst Fibros"},{"issue":"3","key":"2338_CR57","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s10880-012-9346-8","volume":"20","author":"MJ Platten","year":"2013","unstructured":"Platten MJ, Newman E, Quayle E. Self-esteem and its relationship to mental health and quality of life in adults with cystic fibrosis. J Clin Psychol Med Settings. 2013;20(3):392\u20139.","journal-title":"J Clin Psychol Med Settings"},{"issue":"8","key":"2338_CR58","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3109\/09593985.2010.545102","volume":"27","author":"AM Schmidt","year":"2011","unstructured":"Schmidt AM, Jacobsen U, Bregnballe V, et al. Exercise and quality of life in patients with cystic fibrosis: a 12-week intervention study. Physiother Theory Pract. 2011;27(8):548\u201356.","journal-title":"Physiother Theory Pract"},{"issue":"4","key":"2338_CR59","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/ppul.26318","volume":"58","author":"KS McCoy","year":"2023","unstructured":"McCoy KS, Blind J, Johnson T, et al. Clinical change 2 years from start of elexacaftor-tezacaftor-ivacaftor in severe cystic fibrosis. Pediatr Pulmonol. 2023;58(4):1178\u201384.","journal-title":"Pediatr Pulmonol"},{"key":"2338_CR60","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.6061\/clinics\/2017\/e427","volume":"73","author":"DW Gancz","year":"2018","unstructured":"Gancz DW, Cunha MT, Leone C, et al. Quality of life amongst adolescents and young adults with cystic fibrosis: correlations with clinical outcomes. Clin (Sao Paulo). 2018;73:e427.","journal-title":"Clin (Sao Paulo)"},{"issue":"3","key":"2338_CR61","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1183\/09031936.00224911","volume":"41","author":"JM Bradley","year":"2013","unstructured":"Bradley JM, Blume SW, Balp MM, et al. Quality of life and healthcare utilisation in cystic fibrosis: a multicentre study. Eur Respir J. 2013;41(3):571\u20137.","journal-title":"Eur Respir J"},{"issue":"5","key":"2338_CR62","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jcf.2022.05.008","volume":"21","author":"DJ Lee","year":"2022","unstructured":"Lee DJ, Sykes J, Griffin K, et al. The negative impact of chronic rhinosinusitis on the health-related quality of life among adult patients with cystic fibrosis. J Cyst Fibros. 2022;21(5):800\u20136.","journal-title":"J Cyst Fibros"},{"issue":"2","key":"2338_CR63","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/alr.22485","volume":"10","author":"C Safi","year":"2020","unstructured":"Safi C, DiMango E, Keating C, et al. Sinonasal quality-of-life declines in cystic fibrosis patients with pulmonary exacerbations. Int Forum Allergy Rhinol. 2020;10(2):194\u20138.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"10","key":"2338_CR64","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.4187\/respcare.03665","volume":"60","author":"GC Forte","year":"2015","unstructured":"Forte GC, Barni GC, Perin C, et al. Relationship between clinical variables and health-related quality of life in young adult subjects with cystic fibrosis. Respir Care. 2015;60(10):1459\u201368.","journal-title":"Respir Care"},{"issue":"2","key":"2338_CR65","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jpsychores.2007.08.017","volume":"64","author":"J Abbott","year":"2008","unstructured":"Abbott J, Hart A, Morton A, et al. Health-related quality of life in adults with cystic fibrosis: the role of coping. J Psychosom Res. 2008;64(2):149\u201357.","journal-title":"J Psychosom Res"},{"issue":"1","key":"2338_CR66","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1365-2702.2005.01236.x","volume":"15","author":"G Esmond","year":"2006","unstructured":"Esmond G, Butler M, McCormack AM. Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis. J Clin Nurs. 2006;15(1):52\u201360.","journal-title":"J Clin Nurs"},{"key":"2338_CR67","doi-asserted-by":"publisher","first-page":"498","DOI":"10.5604\/17322693.1101598","volume":"68","author":"G D\u0119bska","year":"2014","unstructured":"D\u0119bska G, Cepuch G, Mazurek H. Quality of life in patients with cystic fibrosis depending on the severity of the disease and method of its treatment. Postepy Hig Med Dosw. 2014;68:498\u2013502.","journal-title":"Postepy Hig Med Dosw"},{"issue":"1","key":"2338_CR68","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jcf.2004.12.005","volume":"4","author":"L Gee","year":"2005","unstructured":"Gee L, Abbott J, Hart A, et al. Associations between clinical variables and quality of life in adults with cystic fibrosis. J Cyst Fibros. 2005;4(1):59\u201366.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"2338_CR69","doi-asserted-by":"publisher","first-page":"147","DOI":"10.17219\/acem\/38147","volume":"24","author":"I Uchmanowicz","year":"2015","unstructured":"Uchmanowicz I, Jankowska-Pola\u0144ska B, Rosi\u0144czuk J, et al. Health-related quality of life of patients suffering from cystic fibrosis. Adv Clin Exp Med. 2015;24(1):147\u201352.","journal-title":"Adv Clin Exp Med"},{"key":"2338_CR70","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12955-016-0465-z","volume":"14","author":"CT Solem","year":"2016","unstructured":"Solem CT, Vera-Llonch M, Liu S, et al. Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis. Health Qual Life Outcomes. 2016;14:63.","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"2338_CR71","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jcf.2018.08.001","volume":"18","author":"LS Gold","year":"2019","unstructured":"Gold LS, Patrick DL, Hansen RN, et al. Correspondence between symptoms and preference-based health status measures in the STOP study. J Cyst Fibros. 2019;18(2):251\u201364.","journal-title":"J Cyst Fibros"},{"issue":"6","key":"2338_CR72","first-page":"101637","volume":"54","author":"V Terlizzi","year":"2024","unstructured":"Terlizzi V, Farrell PM. Update on advances in cystic fibrosis towards a cure and implications for primary care clinicians. Curr Probl Pediatr Adolesc Health Care. 2024;54(6):101637.","journal-title":"Curr Probl Pediatr Adolesc Health Care"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-025-02338-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12955-025-02338-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-025-02338-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T16:04:18Z","timestamp":1738685058000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-025-02338-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2338"],"URL":"https:\/\/doi.org\/10.1186\/s12955-025-02338-2","relation":{},"ISSN":["1477-7525"],"issn-type":[{"type":"electronic","value":"1477-7525"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"29 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}